EXHIBIT 10.94 PURCHASE AGREEMENT THIS AGREEMENT is made as of the 30th day of January, 2001, by and between Triangle Pharmaceuticals, Inc. (the "Company"), a corporation organized under the laws of the State of Delaware, with its principal offices at...Purchase Agreement • February 26th, 2001 • Triangle Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment to License Agreement ("Amendment") is entered into as of January 1, 2001 by and between Mitsubishi-Tokyo Pharmaceuticals, Inc., with its principal offices at 2-6, Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8405, Japan, a successor in...License Agreement • February 26th, 2001 • Triangle Pharmaceuticals Inc • Pharmaceutical preparations • New York
RECITALSEmployment Agreement • February 26th, 2001 • Triangle Pharmaceuticals Inc • Pharmaceutical preparations • North Carolina
WITNESSETH:Employment Agreement • February 26th, 2001 • Triangle Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.95 February 12, 2001 Mr. David W. Barry Chief Executive Officer Triangle Pharmaceuticals, Inc. 4 University Place 4611 University Drive Durham, NC 27707 RE: Co-Promotion Agreement between Abbott Laboratories ("Abbott") and Triangle...Co-Promotion Agreement • February 26th, 2001 • Triangle Pharmaceuticals Inc • Pharmaceutical preparations
RE: Co-Promotion Agreement between Abbott Laboratories ("Abbott") and Triangle Pharmaceuticals, Inc. ("Triangle") dated June 2, 1999 (the "Agreement")
